Decreased T-cell repertoire diversity in sepsis: A preliminary study

Critical Care Medicine

Volumn 41, Issue 1, 2013, Pages 111-119

  Venet, Fabienne ^a,b   Filipe Santos, Orchidée ^c   Lepape, Alain ^b,c,d   Malcus, Christophe ^a   Poitevin Later, Françoise ^a   Grives, Audrey ^c   Plantier, Nadia ^c   Pasqual, Nicolas ^c   Monneret, Guillaume ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CEA GRENOBLE   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

divpenia; lymphocyte; septic shock; T cell receptor diversity

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; AGED; ARTICLE; BLOOD; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; SEPTIC SHOCK;

ADULT; AGED; CROSS INFECTION; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GENETIC VARIATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REFERENCE VALUES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 84872059919     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182657948     Document Type: Article

References (36)

1. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
2. Carlet J, Cohen J, Calandra T, et al: Sepsis: Time to reconsider the concept. Crit Care Med 2008; 36:964-966
3. Monneret G, Venet F, Pachot A, et al: Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med 2008; 14:64-78
4. Meakins JL, Pietsch JB, Bubenick O, et al: Delayed hypersensitivity: Indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg 1977; 186:241-250
5. Derouazi M, Wang Y, Marlu R, et al: Optimal epitope composition after antigen screening using a live bacterial delivery vector: Application to TRP-2. Bioeng Bugs 2010; 1:51-60
6. Banerjee P, Tripp A, Lairmore MD, et al: Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 2010; 115:2640-2648
7. Marodon G, Desjardins D, Mercey L, et al: High diversity of the immune repertoire in humanized NOD. SCID. gamma c-/-mice. Eur J Immunol 2009; 39:2136-2145
8. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
9. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
10. Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793-1800
11. European Centre for Disease Prevention and Control: Definition of ICU-acquired infections. Available at: http://ecdc. europa. eu/en/activities/ surveillance/hai/about-hai-net/pages/icu. aspx. Accessed December 5, 2011
12. Venet F, Davin F, Guignant C, et al: Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 2010; 34: 358-363
13. Monneret G, Lepape A, Voirin N, et al: Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006; 32:1175-1183
14. Monneret G, Debard AL, Venet F, et al: Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003; 31:2068-2071
15. Hotchkiss RS, Chang KC, Swanson PE, et al: Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte. Nat Immunol 2000; 1:496-501
16. Shelley O, Murphy T, Paterson H, et al: Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 2003; 20:123-129
17. Boomer JS, To K, Chang KC, et al: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 306: 2594-2605
18. Naylor K, Li G, Vallejo AN, et al: The influence of age on T cell generation and TCR diversity. J Immunol 2005; 174:7446-7452
19. Nikolich-Zugich J, Slifka MK, Messaoudi I: The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004; 4:123-132
20. Gorochov G, Neumann AU, Kereveur A, et al: Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998; 4:215-221
21. Meyer-Olson D, Shoukry NH, Brady KW, et al: Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med 2004; 200:307-319
22. Naesens M, Sarwal MM: Harnessing the diversity of the human T-cell repertoire: A monitoring tool for transplantation tolerance? Eur J Immunol 2010; 40:2986-2989
23. Miqueu P, Degauque N, Guillet M, et al: Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol 2010; 40:3280-3290
24. Heininger A, Haeberle H, Fischer I, et al: Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011; 15:R77
25. Kalil AC, Florescu DF: Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009; 37:2350-2358
26. Ferry T, Thomas D, Perpoint T, et al: Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Clin Microbiol Infect 2008; 14:546-554
27. Unsinger J, Kazama H, McDonough JS, et al: Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury. J Leukoc Biol 2009; 85:382-390
28. van den Beemd R, Boor PP, van Lochem EG, et al: Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000; 40:336-345
29. Monserrat J, de Pablo R, Reyes E, et al: Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care 2009; 13:R26
30. Roth G, Moser B, Krenn C, et al: Susceptibility to programmed cell death in T-lymphocytes from septic patients: A mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun 2003; 308:840-846
31. Skrupky LP, Kerby PW, Hotchkiss RS: Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology 2011; 115:1349-1362
32. Hotchkiss RS, Opal S: Immunotherapy for sepsis-A new approach against an ancient foe. N Engl J Med 2010; 363:87-89
33. Mackall CL, Fry TJ, Gress RE: Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011; 11:330-342
34. Sportès C, Hakim FT, Memon SA, et al: Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008; 205:1701-1714
35. Unsinger J, McGlynn M, Kasten KR, et al: IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010; 184:3768-3779
36. Kasten KR, Prakash PS, Unsinger J, et al: Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun 2010; 78:4714-4722